TSS
ABCL icon

Two Sigma Securities’s AbCellera Biologics ABCL Stock Holding History

Two Sigma Securities’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.5K Sell
10,163
-58,121
-85% -$209K ﹤0.01% 1305
2025
Q4 		$234K Buy
68,284
+55,239
+423% +$247K 0.03% 775
2025
Q3 		$65.6K Buy
+13,045
New +$57.5K 0.01% 956
2023
Q2 		– Sell
-11,212
Closed -$84.5K – 2721
2023
Q1 		$84.5K Buy
+11,212
New +$102K ﹤0.01% 2224

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Securities's ABCL Position: Q1 2026 in Review

Two Sigma Securities reduced its AbCellera Biologics (ABCL) stake by 85% in Q1 2026, selling an estimated $209K and leaving 10,163 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1305.

Two Sigma Securities first reported a position in ABCL in Q1 2023 and has held it in 4 quarters since. The position peaked at $234K in Q4 2025. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Two Sigma Securities held 10,163 shares of AbCellera Biologics worth $35.5K as of Q1 2026.
  • Two Sigma Securities sold 58,121 AbCellera Biologics shares in Q1 2026, an estimated $209K.
  • AbCellera Biologics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1305 holding.
  • Two Sigma Securities first reported a position in AbCellera Biologics in Q1 2023 and has held it in 4 quarters since.
  • Two Sigma Securities's AbCellera Biologics position peaked at $234K in Q4 2025.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.